Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-fluorophenyl)-6-fluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
2. 1-ffmpoc
3. 6-fluoro-1-(4-fluorophenyl)-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-quinolone-3-carboxylic Acid
4. A 56619
5. A-56619
6. Dicural
7. Difloxacin Hydrochloride
1. 98106-17-3
2. Difloxacin [inn]
3. 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
4. Dicural
5. 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic Acid
6. Pulsaflox
7. Difloxacin (inn)
8. 5z7oo9fnfd
9. Chebi:4537
10. 6-fluoro-1-(4-fluorophenyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic Acid
11. Difloxacin (hydrochloride)
12. A 56619
13. 3-quinolinecarboxylic Acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-
14. 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic Acid
15. A-56619
16. Difloxacin Hydrochloride Salt
17. 3-quinolinecarboxylic Acid,6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-
18. Ncgc00166308-01
19. Unii-5z7oo9fnfd
20. Difloxacin [mi]
21. Chembl6259
22. Schembl148765
23. Dtxsid5048348
24. Gtpl10801
25. Bcp33408
26. Rkl10076
27. Zinc4099034
28. Bbl010805
29. Stk618168
30. Zinc04099034
31. Akos005551754
32. Db11511
33. Difloxacin [ema Epar Veterinary]
34. Ac-12060
35. Ls-14845
36. Db-057711
37. Hy-121272
38. Cs-0081346
39. Ft-0624916
40. D07828
41. Ab00923781_02
42. Ab00923781_04
43. 106d173
44. A843794
45. A845811
46. A858583
47. Q5275450
48. 4-(4-hydroxy-4-p-tolylpiperidin-1-yl)-1-phenylbutan-1-one
49. 6-fluoro-1-(4-fluorophenyl)-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid
50. 3-quinolinecarboxylic Acid, 6-fluoro-1-(4-fluorophenyl) 1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-
51. 6-fluoranyl-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxidanylidene-quinoline-3-carboxylic Acid
52. 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4- Methyl-1- Piperazinyl)-4-oxo-3- Quinolinecarboxylic Acid
53. 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic Acid;difluoxacin Hydrochloride
54. 6-fluoro-1-(p-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid
| Molecular Weight | 399.4 g/mol |
|---|---|
| Molecular Formula | C21H19F2N3O3 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 399.13944780 g/mol |
| Monoisotopic Mass | 399.13944780 g/mol |
| Topological Polar Surface Area | 64.1 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 672 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
* Chickens: :
for the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
* Turkeys: :
- For the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
- Also for the treatment of infections caused by Pasteurella multocida.
* Dogs: :
- For the treatment of acute uncomplicated urinary-tract infections caused by Escherichia coli or Staphylococcus spp. and superficial pyoderma caused by Staphylococcus intermedius.
* Cattle: :
- For the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida and / or Mycoplasma spp.
In chickens and turkeys Pulsaflox oral solution is indicated for treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
In turkeys Pulsaflox oral solution is also indicated for the treatment of infections caused by Pasteurella multocida.
Pulsaflox oral solution should only be used based on susceptibility testing.
QJ01MA94
QJ01MA
API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Difloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Difloxacin, including repackagers and relabelers. The FDA regulates Difloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Difloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Difloxacin supplier is an individual or a company that provides Difloxacin active pharmaceutical ingredient (API) or Difloxacin finished formulations upon request. The Difloxacin suppliers may include Difloxacin API manufacturers, exporters, distributors and traders.
Difloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Difloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Difloxacin GMP manufacturer or Difloxacin GMP API supplier for your needs.
A Difloxacin CoA (Certificate of Analysis) is a formal document that attests to Difloxacin's compliance with Difloxacin specifications and serves as a tool for batch-level quality control.
Difloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Difloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Difloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Difloxacin EP), Difloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Difloxacin USP).
LOOKING FOR A SUPPLIER?
